Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.

doi:10.1186/s12967-022-03383-x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.

Journal of translational medicine - 17 May 2022

Avian Alice, Clemente Nicolò, Mauro Elisabetta, Isidoro Erica, Di Napoli Michela, Dudine Sandra, Del Fabro Anna, Morini Stefano, Perin Tiziana, Giudici Fabiola, Cammisuli Tamara, Foschi Nicola, Mocenigo Marco, Montrone Michele, Modena Chiara, Polenghi Martina, Puzzi Luca, Tomaic Vjekoslav, Valenti Giulio, Sola Riccardo, Zanolla Shivani, Vogrig Enea, Riva Elisabetta, Angeletti Silvia, Ciccozzi Massimo, Castriciano Santina, Pachetti Maria, Petti Matteo, Centonze Sandro, Gerin Daniela, Banks Lawrence, Marini Bruna, Canzonieri Vincenzo, Sopracordevole Francesco, Zanconati Fabrizio, Ippodrino Rudy

Abstract excerpt

BACKGROUND: According to international guidelines, Human Papillomavirus (HPV) DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more (CIN2+) lesions. The study aimed to assess whether HPV Selfy (Ulisse BioMed - Trieste, Italy), a full-genotyping HPV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Genotype

Share to Mass Screening

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35581584
DOI: 10.1186/s12967-022-03383-x
PMCID: PMC9115952

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.PMID 35581584Read ↗

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.Semantic proximity Read ↗

Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.Semantic proximity Read ↗

Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.Semantic proximity Read ↗

Self-Sampling for HPV Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening ProgramsSemantic proximity Read ↗

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples.Semantic proximity Read ↗

Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.Semantic proximity Read ↗

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.Semantic proximity Read ↗

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningSemantic proximity Read ↗

[Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].Semantic proximity Read ↗

Validity and Acceptance of Self vs Conventional Sampling for the Analysis of Human Papillomavirus and Pap SmearSemantic proximity Read ↗

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.Semantic proximity Read ↗

Development and Validation of a New HPV Genotyping Assay Based on Next-Generation SequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.